Advertisement

Insuffisant moteur cérébral à potential ambulatoire et baclofène intrathécal

  • P. Filipetti
  • É. Kolanowski
  • C. Bleyenheuft
  • P. Menei
  • P. Decq
  • Y. Delpierre

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Ben Smaïl D, Kiefer C, Bussel B (2003) Évaluation clinique de la spasticité, Neurochirurgie, 49, no 2–3, 190–8PubMedGoogle Scholar
  2. 2.
    Bussel B (2003) Spasticité: bilan et perspectives, Neurochirurgie, 49, no 2–3, 413–6PubMedGoogle Scholar
  3. 3.
    Decq P (2003) Physiopathologie de la spasticité, Neurochirurgie, 49, no 2–3, 163–84PubMedGoogle Scholar
  4. 4.
    Gormley ME, Krach LE, Piccini L (2001) Spasticity management in the child with spastic quadriplegia, European Journal of Neurology, 8(suppl. 5): 127–35PubMedGoogle Scholar
  5. 5.
    Rodda J, Graham HK (2001) Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm, European Journal of Neurology, 8(suppl. 5): 98–108PubMedGoogle Scholar
  6. 6.
    Filipetti P, Kolanowski E, Barbedette B et al. (2003) Intrathecal baclofen therapy and cerebral palsy. Extenal programmable pump procedure in spastic diplegia, ESMAC, Marseille, FranceGoogle Scholar
  7. 7.
    Ashworth B (1964) Preliminary trial of carisprodol in multiple sclerosis. Practitionner 192: 540–2Google Scholar
  8. 8.
    Romei M, Galli M, Motta F et al. (2003) Use of the normalcy index for the evaluation of gait pathology, Gait and Posture 00 1–7Google Scholar
  9. 9.
    Albright AL (1996) Baclofen in the treatment of cerebral palsy, Journal of Child Neurology, vol. 11, no2: 77–83PubMedGoogle Scholar
  10. 10.
    Albright AL (1992) Neurosurgical treatment of spasticity: selective posterior rhizotomy and intrathecal baclofen, Steroeotact Funct Neurosurg 58: 3–13Google Scholar
  11. 11.
    Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin, JAMA, November 24, vol. 270, no 20Google Scholar
  12. 12.
    Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy, JAMA, vol. 265, no 11Google Scholar
  13. 13.
    Albright AL, Shultz B (1999) Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion, Journal of Child Neurology, vol. 14: 408–9PubMedGoogle Scholar
  14. 14.
    Armstrong RW, Steinbok P, Cochrane DD et al. (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin, J Neurosurg, vol. 87: 409–14PubMedGoogle Scholar
  15. 15.
    Creedon SD, Dijkers MPJM, Hinderer SR (1997) Intrathecal baclofen for severe spasticity: a meta-analysis, International Journal of Rehabilitation and Health; vol. 3, no3: 171–85Google Scholar
  16. 16.
    Gerszten PC, Albright AL, Barry MJ (1997) Effect on ambulation of continuous intrathecal baclofen infusion, Pediatr Neurosurg vol. 27: 40–4PubMedGoogle Scholar
  17. 17.
    Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy, J. Neurosurg., 88: 1009–13PubMedGoogle Scholar
  18. 18.
    Gilmartin R, Bruce D, Storrs BB et al. (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial, Journal of Child Neurology,. vol. 15, no2: 71–7PubMedGoogle Scholar
  19. 19.
    Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity, Neurosurgery, vol. 45, no4: 833–7CrossRefPubMedGoogle Scholar
  20. 20.
    Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal baclofen, Journal of Child Neurology, vol. 16, no 1: 31–6PubMedGoogle Scholar
  21. 21.
    Murphy NA, Irwin MCN, Hoff C (2002) Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications, Arch Phys Med Rehab, vol. 83: 1721–5Google Scholar
  22. 22.
    Narayan RK, Loubser PG, Jankovic J et al. (1991) Intrathecal baclofen for intractable axial dystonia, Neurology; 41: 1141–2PubMedGoogle Scholar
  23. 23.
    Sallerin B, Lazorthes Y (2003) Baclofène intrathécal: historique, preuves expérimentales et données pharmacocinétiques, Neurochirurgie, 49, no 2–3, 271–5PubMedGoogle Scholar
  24. 24.
    Sampson FC, Hayward A, Evans G et al. (2002) Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity, J. Neurosurg., 96: 1052–7PubMedGoogle Scholar
  25. 25.
    Van Schaeybroeck P, Nuttin B, Lagae L et al. (2000) Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study, Neurosurgery, vol. 46, no 3: 603–12PubMedGoogle Scholar
  26. 26.
    Von Koch CS, Park TS, Steinbok P et al. (2001) Selective posterior rhizotomy and intrathecal baclofen for the treatment of spasticity, Pediatr Neurosurg; 35: 57–65Google Scholar
  27. 27.
    Albright AL, Barry MJ, Painter MJ et al. (1998) Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy, J Neurosurg vol. 88: 73–6PubMedGoogle Scholar
  28. 28.
    Butler C, Campbell S (2000) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy, Developmental Medicine & Child Neurology, 42: 634–45CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2005

Authors and Affiliations

  • P. Filipetti
    • 1
  • É. Kolanowski
    • 2
  • C. Bleyenheuft
    • 2
  • P. Menei
    • 3
  • P. Decq
    • 4
  • Y. Delpierre
    • 2
  1. 1.Médecine physique et réadaptationCentre de l’ArcheSaint-Saturnin
  2. 2.Unité d’analyse quantifyé du mouvementCentre régional spécialisé de l’ArcheLe Mans
  3. 3.Service de neurochirurgieCHU d’AngersAnger
  4. 4.Service de neurochirurgieHôpital Henri MondorCréteil

Personalised recommendations